Ricardo R. Fernandes

National Institute of Cancer - INCA, Brazil

Presentation(s):

• L-2J - Cost-utility of Nivolumab for Treatment of Head and Neck Cancer from a Brazilian Public Health System Perspective

  Monday, August 23, 2021
  6:30 PM – 7:30 PM US Eastern Time